Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126148371 | 12614837 | 1 | I | 20160503 | 20160503 | 20160802 | 20160802 | EXP | PH-TAKEDA-2016MPI003920 | TAKEDA | 57.92 | YR | F | Y | 0.00000 | 20160802 | OT | PH | PH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126148371 | 12614837 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Unknown | 1.8 MG, Q2WEEKS | 21602 | 1.8 | MG | INJECTION | QOW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126148371 | 12614837 | 1 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126148371 | 12614837 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126148371 | 12614837 | Abdominal pain upper | |
| 126148371 | 12614837 | Asthma | |
| 126148371 | 12614837 | Diarrhoea | |
| 126148371 | 12614837 | Dizziness | |
| 126148371 | 12614837 | Malaise | |
| 126148371 | 12614837 | Nasopharyngitis | |
| 126148371 | 12614837 | Nausea | |
| 126148371 | 12614837 | Pyrexia | |
| 126148371 | 12614837 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |